Invitae Corporation, a leading medical genetics company, has published its 2024 Environmental, Social and Governance (ESG) Report. This report provides a comprehensive overview of the company’s ESG approach, performance, and progress measured through the 2023 fiscal year.
Invitae emphasizes sustainability and ESG as catalysts for transformative change, with a unwavering commitment to positively impacting healthcare, the environment, and society. The report highlights notable achievements in ESG initiatives, including:
* Enhancing data security and privacy measures to safeguard patient information.
* Expanding access to genetic testing and services for underserved communities.
* Promoting diversity, equity, and inclusion within the workplace and beyond.
* Reducing carbon emissions and waste generation through sustainable practices.
* Engaging with stakeholders to address ESG issues.
Invitae’s full 2024 ESG Report is available for download on the company’s website.
